Inhibitory functioning in Alzheimer's disease

被引:213
|
作者
Amieva, H
Phillips, LH
Della Sala, S
Henry, JD
机构
[1] Univ Bordeaux 2, INSERM, U593, F-33076 Bordeaux, France
[2] Univ Aberdeen, Dept Psychol, Aberdeen AB9 1FX, Scotland
关键词
inhibition; ageing; dementia; Alzheimer's disease;
D O I
10.1093/brain/awh045
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We present a comprehensive review of studies assessing inhibitory functioning in Alzheimer's disease. The objectives of this review are: (i) to establish whether Alzheimer's disease affects all inhibitory mechanisms equally, and (ii) where possible, to assess whether any effects of Alzheimer's disease on inhibition tasks might be caused by other cognitive deficits, such as slowed processing. We review inhibitory mechanisms considered to play a crucial role in various domains of cognition, such as inhibition involved in working memory, selective attention and shifting abilities, and the inhibition of motor and verbal responses. It was found that whilst most inhibitory mechanisms are affected by the disorder, some are relatively preserved, suggesting that inhibitory deficits in Alzheimer's disease may not be the result of a general inhibitory breakdown. In particular, the experimental results reviewed showed that Alzheimer's disease has a strong effect on tasks requiring controlled inhibition processes, such as the Stroop task. However, the presence of the disease appears to have relatively little effect on tasks requiring more automatic inhibition, such as the inhibition of return task. Thus, the distinction between automatic, reflexive inhibitory mechanisms and controlled inhibitory mechanisms may be critical when predicting the integrity of inhibitory mechanisms in Alzheimer's disease. Substantial effects of Alzheimer's disease on tasks such as negative priming, which are not cognitively complex but do require some degree of controlled inhibition, support this hypothesis. A meta-analytic review of seven studies on the Stroop paradigm revealed substantially larger effects of Alzheimer's disease on the inhibition condition relative to the baseline condition, suggesting that these deficits do not simply reflect general slowing.
引用
收藏
页码:949 / 964
页数:16
相关论文
共 50 条
  • [41] New pharmacological options in the treatment of Alzheimer's disease
    Kleinova, L.
    Cerman, J.
    Hlavka, J.
    Hort, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2022, 85 (06) : 462 - 469
  • [42] Attitudes and Perceptions Regarding Alzheimer's Disease in Greece
    Tsolaki, Magda
    Paraskevi, Sakka
    Degleris, Nicolaos
    Karamavrou, Sofia
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2009, 24 (01): : 21 - 26
  • [43] The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort
    Caroli, A.
    Frisoni, G. B.
    NEUROBIOLOGY OF AGING, 2010, 31 (08) : 1263 - 1274
  • [44] Certified normal: Alzheimer's disease biomarkers and normative estimates of cognitive functioning
    Hassenstab, Jason
    Chasse, Rachel
    Grabow, Perri
    Benzinger, Tammie L. S.
    Fagan, Anne M.
    Xiong, Chengjie
    Jasielec, Mateusz
    Grant, Elizabeth
    Morris, John C.
    NEUROBIOLOGY OF AGING, 2016, 43 : 23 - 33
  • [45] Age-related reduction in brain ACE-2 is not exacerbated by Alzheimer's disease pathology in mouse models of Alzheimer's disease
    MacLachlan, Robert
    Evans, Charles E.
    Chai, Siew Yeen
    Good, Mark A.
    Kehoe, Patrick Gavin
    Miners, J. Scott
    AGING BRAIN, 2023, 3
  • [46] Mitochondria and Alzheimer's disease
    Piaceri, Irene
    Rinnoci, Valentina
    Bagnoli, Silvia
    Failli, Ylenia
    Sorbi, Sandro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 322 (1-2) : 31 - 34
  • [47] Misconceptions of Alzheimer's Disease
    Lowe, Deborah A.
    Balsis, Steve
    Hughes, Matthew L.
    Shine, Hannah E.
    Carpenter, Brian D.
    CLINICAL GERONTOLOGIST, 2015, 38 (02) : 149 - 156
  • [48] Pharmacogenomics of Alzheimer's disease
    Takeda, Masatoshi
    Martinez, Rocio
    Kudo, Takashi
    Tanaka, Toshihisa
    Okochi, Masayasu
    Tagami, Shinji
    Morihara, Takashi
    Hashimoto, Ryota
    Cacabelos, Ramon
    ASIA-PACIFIC PSYCHIATRY, 2011, 3 (01) : 10 - 16
  • [49] Alzheimer's disease and depression
    Gallarda, T
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1999, 25 : 14 - +
  • [50] The neurochemistry of Alzheimer's disease
    Engelborghs, S
    DeDeyn, PP
    ACTA NEUROLOGICA BELGICA, 1997, 97 (02) : 67 - 84